Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from Twist Bioscience Corporation’s reported figures.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
FAQ
- What is Twist Bioscience Corporation's EBITDA?
- Twist Bioscience Corporation (TWST) reported EBITDA of -$39.45M in Q1 2026.
- How has Twist Bioscience Corporation's EBITDA changed year-over-year?
- Twist Bioscience Corporation's EBITDA decreased by 12.2% year-over-year, from -$35.16M to -$39.45M.
- What is the long-term trend for Twist Bioscience Corporation's EBITDA?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's EBITDA has grown at a -6.0% compound annual growth rate (CAGR), from -$142.98M to -$111.41M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Twist Bioscience Corporation's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude